News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs
Photo from Nieves Martinez Lago/X
Apr 14, 2024, 11:39

Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs

Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter:

“FDA approvals Tumor-Agnostic drugs:

  1. dMMR
  2. Pembrolizumab 2017
  3. Dostarlimab 2022
  4. MSI-H
  5. Pembrolizumab 2017
  6. TMB-High
  7. Pembrolizumab 2020
  8. NTRK fusions
  9. Larotrectinib 2018
  10. Entrectinib 2019
  11. BRAF V600E
  12. Dabrafenib + Trametinib 2022
  13. RET fusions
  14. Selpercatinib 2022
  15. HER2 3+
  16. T-derutxecan 2024.”

Source: Nieves Martinez Lago/X

BRAF V600E cancer dabrafenib dMMR Dostarlimab Drugs Entrectinib HER2 3+ larotrectinib MSI-H NTRK fusions OncoDaily Oncology pembrolizumab RET fusions Selpercatinib T-derutxecan TMB-High Trametinib Tumor-agnostic University Hospital Complex of Ferrol
Special Coverage
Insight
Nov 3, 2024, 17:46
Rana McKay: Evaluating ACP1 expression in prostrate cancer
Insight
Nov 3, 2024, 17:23
Talha Badar: A predictive model for therapy failure in patients with CML receiving TKI therapy
Insight
Nov 3, 2024, 17:05
Vincent Rajkumar: Survival improvement in patients with HIV associated B cell lymphoma that adopted the Medicaid expansion of ACA
Blog
Nov 3, 2024, 16:51
Addressing cancer disparities among Black women - American Cancer Society
Blog
Nov 3, 2024, 16:48
Mohit Manrao: Discussing cancer innovation and biomarkers at the STAT Summit
Blog
Nov 3, 2024, 16:46
Lindsey Gasparini: New FDA-approved therapy targets Claudin18.2 in gastric cancers
Blog
Nov 3, 2024, 16:45
Nermean Mostafa: Launching a new oncology training platform in Egypt
Blog
Nov 3, 2024, 16:35
Jasmine Kamboj: Honored to be on the ballot for the Designated Community Oncology seat
Blog
Nov 3, 2024, 16:34
Crystal Denlinger: Our biannual guidelines harmonization update meeting
Blog
Nov 3, 2024, 16:30
Yale University's $150M investment into AI leadership is equipping medstudents with the tools to tackle tomorrow's healthcare challenges
Insight
Nov 3, 2024, 16:27
Alessandro Di Federico: EFS in patients with resectable NSCLC treated with neoadjuvant Chemo-IO
Blog
Nov 3, 2024, 16:25
Raising awareness on biomarker information gaps for metastatic breast cancer patients - ABC Global Alliance